TY - JOUR
T1 - Assessing Subject Privacy and Data Confidentiality in an Emerging Region for Clinical Trials
T2 - United Arab Emirates
AU - Nair, Satish Chandrasekhar
AU - Ibrahim, Halah
N1 - Publisher Copyright:
© , Copyright © Taylor & Francis Group, LLC.
PY - 2015/7/4
Y1 - 2015/7/4
N2 - Pharmaceutical sponsored clinical trials, formerly conducted predominantly in the United States and Europe, have expanded to emerging regions, including the Middle East. Our study explores factors influencing clinical trial privacy and confidentiality in the United Arab Emirates. Factors including concept familiarity, informed consent compliance, data access, and preservation, were analyzed to assess current practices in the Arab world. As the UAE is an emerging region for clinical trials, there is a growing need for regulations related to data confidentiality and subject privacy. Informational and decisional privacy should be viewed within the realms of Arab culture and religious background.
AB - Pharmaceutical sponsored clinical trials, formerly conducted predominantly in the United States and Europe, have expanded to emerging regions, including the Middle East. Our study explores factors influencing clinical trial privacy and confidentiality in the United Arab Emirates. Factors including concept familiarity, informed consent compliance, data access, and preservation, were analyzed to assess current practices in the Arab world. As the UAE is an emerging region for clinical trials, there is a growing need for regulations related to data confidentiality and subject privacy. Informational and decisional privacy should be viewed within the realms of Arab culture and religious background.
KW - culture
KW - privacy and confidentiality
KW - regulatory
UR - http://www.scopus.com/inward/record.url?scp=84928593459&partnerID=8YFLogxK
U2 - 10.1080/08989621.2014.942452
DO - 10.1080/08989621.2014.942452
M3 - Article
C2 - 25897766
AN - SCOPUS:84928593459
SN - 0898-9621
VL - 22
SP - 205
EP - 220
JO - Accountability in Research
JF - Accountability in Research
IS - 4
ER -